Anca Remes

614 total citations
23 papers, 388 citations indexed

About

Anca Remes is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anca Remes has authored 23 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Genetics and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anca Remes's work include Virus-based gene therapy research (6 papers), Connective tissue disorders research (6 papers) and CRISPR and Genetic Engineering (5 papers). Anca Remes is often cited by papers focused on Virus-based gene therapy research (6 papers), Connective tissue disorders research (6 papers) and CRISPR and Genetic Engineering (5 papers). Anca Remes collaborates with scholars based in Germany, Netherlands and Romania. Anca Remes's co-authors include Oliver J. Müller, Norbert Frey, Andreas H. Wagner, Susanne Hille, Rawa Arif, Ilinca Gussi, Livia Elena Sima, Jihad El Andari, Thorsten Lamla and Dirk Grimm and has published in prestigious journals such as Nature Medicine, Nature Communications and Scientific Reports.

In The Last Decade

Anca Remes

21 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anca Remes Germany 9 224 182 85 65 58 23 388
Belén Prados Spain 11 417 1.9× 61 0.3× 174 2.0× 25 0.4× 57 1.0× 12 559
Bryan A. Piras United States 13 290 1.3× 132 0.7× 120 1.4× 40 0.6× 89 1.5× 16 450
Yoko Obara Japan 5 260 1.2× 218 1.2× 18 0.2× 99 1.5× 37 0.6× 6 396
Frances Lloyd Australia 7 519 2.3× 206 1.1× 54 0.6× 88 1.4× 44 0.8× 10 623
Jim Swildens Netherlands 11 180 0.8× 33 0.2× 82 1.0× 79 1.2× 89 1.5× 15 328
Robert E. Welikson United States 14 385 1.7× 113 0.6× 146 1.7× 34 0.5× 92 1.6× 18 487
Shihoko Sata Japan 5 226 1.0× 68 0.4× 16 0.2× 45 0.7× 100 1.7× 7 384
Marlinde L. van den Boogaard Netherlands 11 290 1.3× 58 0.3× 46 0.5× 72 1.1× 16 0.3× 17 392
Suet‐Ping Wong United Kingdom 8 211 0.9× 93 0.5× 11 0.1× 63 1.0× 36 0.6× 10 338
Emma A. Hall United Kingdom 7 544 2.4× 285 1.6× 49 0.6× 10 0.2× 125 2.2× 10 679

Countries citing papers authored by Anca Remes

Since Specialization
Citations

This map shows the geographic impact of Anca Remes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anca Remes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anca Remes more than expected).

Fields of papers citing papers by Anca Remes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anca Remes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anca Remes. The network helps show where Anca Remes may publish in the future.

Co-authorship network of co-authors of Anca Remes

This figure shows the co-authorship network connecting the top 25 collaborators of Anca Remes. A scholar is included among the top collaborators of Anca Remes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anca Remes. Anca Remes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Remes, Anca, et al.. (2025). Infection and herbicide exposure implicate c-Abl kinase in α-Synuclein Ser129 phosphorylation. Cell Communication and Signaling. 23(1). 396–396. 1 indexed citations
2.
Müller, Oliver J., Susanne Hille, & Anca Remes. (2025). Cardiac gene therapy makes a comeback. Nature Medicine. 31(11). 3616–3617.
3.
Schröder, Lena, Susanne Hille, Anca Remes, et al.. (2025). Directed Evolution of AAV9 for Efficient Gene Expression in Cardiomyocytes In Vitro and In Vivo. Human Gene Therapy. 36(3-4). 101–115. 1 indexed citations
4.
Schröder, Lena, Anca Remes, Susanne Hille, et al.. (2024). AAV library screening identifies novel vector for efficient transduction of human aorta. Gene Therapy. 32(2). 154–162. 2 indexed citations
5.
Bozoglu, Tarik, Susanne Hille, Anja Wolf, et al.. (2023). Regnase-1 overexpression as a therapeutic approach of Marfan syndrome. Molecular Therapy — Methods & Clinical Development. 32(1). 101163–101163. 4 indexed citations
6.
Hille, Susanne, Anca Remes, Inga Schmidt, et al.. (2023). Fibin regulates cardiomyocyte hypertrophy and causes protein-aggregate-associated cardiomyopathy in vivo. Frontiers in Molecular Biosciences. 10. 1169658–1169658. 2 indexed citations
7.
Remes, Anca, et al.. (2023). Adapted clustering method for generic analysis of histological fibrosis staining as an open source tool. Scientific Reports. 13(1). 4389–4389. 4 indexed citations
9.
Remes, Anca, Jakob Körbelin, Caroline Arnold, et al.. (2022). Adeno-Associated Virus-Mediated Gene Transfer of Inducible Nitric Oxide Synthase to an Animal Model of Pulmonary Hypertension. Human Gene Therapy. 33(17-18). 959–967. 5 indexed citations
10.
Mohr, F., Anca Remes, Rawa Arif, et al.. (2022). Short-term rapamycin treatment increases life span and attenuates aortic aneurysm in a murine model of Marfan-Syndrome. Biochemical Pharmacology. 205. 115280–115280. 12 indexed citations
11.
Remes, Anca, Andreas H. Wagner, Markus Heckmann, et al.. (2021). AAV-mediated expression of NFAT decoy oligonucleotides protects from cardiac hypertrophy and heart failure. Basic Research in Cardiology. 116(1). 38–38. 12 indexed citations
12.
Remes, Anca, Thomas Puehler, Susanne Hille, et al.. (2021). Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue. Molecular Therapy — Methods & Clinical Development. 21. 83–93. 22 indexed citations
13.
Weinmann, Jonas, Warut Tulalamba, Anca Remes, et al.. (2020). Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants. Nature Communications. 11(1). 5432–5432. 168 indexed citations
14.
Remes, Anca, et al.. (2020). Gene transfer to the vascular system: Novel translational perspectives for vascular diseases. Biochemical Pharmacology. 182. 114265–114265. 8 indexed citations
15.
Remes, Anca, Maximilian Franz, Norbert Frey, et al.. (2020). AAV-mediated TIMP-1 overexpression in aortic tissue reduces the severity of allograft vasculopathy in mice. The Journal of Heart and Lung Transplantation. 39(4). 389–398. 6 indexed citations
16.
Rangrez, Ashraf Yusuf, Anca Remes, Manju Kumari, et al.. (2020). The E3 ubiquitin ligase HectD3 attenuates cardiac hypertrophy and inflammation in mice. Communications Biology. 3(1). 562–562. 18 indexed citations
17.
Remes, Anca, Maximilian Franz, F. Mohr, et al.. (2019). AAV-Mediated Expression of AP-1-Neutralizing RNA Decoy Oligonucleotides Attenuates Transplant Vasculopathy in Mouse Aortic Allografts. Molecular Therapy — Methods & Clinical Development. 15. 246–256. 7 indexed citations
18.
Wagner, Andreas H., et al.. (2019). Marfan syndrome: A therapeutic challenge for long-term care. Biochemical Pharmacology. 164. 53–63. 24 indexed citations
19.
Arif, Rawa, Anca Remes, Philipp Seppelt, et al.. (2017). AP-1 Oligodeoxynucleotides Reduce Aortic Elastolysis in a Murine Model of Marfan Syndrome. Molecular Therapy — Nucleic Acids. 9. 69–79. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026